Mercks

U.S. federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy. The Food and…

Merck's antiviral COVID-19 pill can reduce risk of death from the virus by 30%, study findsA new antiviral COVID-19 pill can cut risk of hospitalization and death from Covid by 30%, a new study findsThe data was published…

<!-- -->The data will be at the center of a panel discussion by US Food and Drug Administration advisersMerck & Co said updated results showed its Covid-19 pill reduced the risk of hospitalization or death among adults with mild…

Merck & Co Inc said on Friday its experimental COVID-19 pill reduced the risk of hospitalization and death by 30% in a study, according to data from all the patients enrolled in a late-stage study. The company said the data…

The U.S. government will buy another $1 billion worth of the COVID-19 pill made by Merck & Co Inc (MRK.N) and partner Ridgeback Biotherapeutics, the companies said on Tuesday. The government in June agreed to buy 1.7 million courses of…

The United Kingdom granted conditional authorization Thursday to the first pill officially shown to successfully treat COVID-19. It's the first country to OK the treatment from drugmaker Merck, but it is not known when the pill will be…

Britain has granted a conditional authorization to Merck's coronavirus antiviral, the first pill shown to successfully treat COVID-19. It is the first country to OK the treatment, although it was not immediately clear how quickly the pill…

The Merck logo is seen at a gate to the Merck &amp; Co campus in Rahway, New Jersey, U.S., July 12, 2018.Brendan McDermid | ReutersLONDON — An antiviral pill found to be effective at treating Covid-19 has been approved by Britain's…

BENGALURU: Everest Organics said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate Covid-19. Shares of…

Dr. Scott Gottlieb explained why he's optimistic about Merck's Covid antiviral pill after the drugmaker asked the Food and Drug Administration Monday to authorize its pill to treat people with mild to moderate Covid symptoms. "The topline…